UniProt ID | MTA2_HUMAN | |
---|---|---|
UniProt AC | O94776 | |
Protein Name | Metastasis-associated protein MTA2 | |
Gene Name | MTA2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 668 | |
Subcellular Localization | Nucleus . | |
Protein Description | May be involved in the regulation of gene expression as repressor and activator. The repression might be related to covalent modification of histone proteins.. | |
Protein Sequence | MAANMYRVGDYVYFENSSSNPYLVRRIEELNKTANGNVEAKVVCLFRRRDISSSLNSLADSNAREFEEESKQPGVSEQQRHQLKHRELFLSRQFESLPATHIRGKCSVTLLNETDILSQYLEKEDCFFYSLVFDPVQKTLLADQGEIRVGCKYQAEIPDRLVEGESDNRNQQKMEMKVWDPDNPLTDRQIDQFLVVARAVGTFARALDCSSSIRQPSLHMSAAAASRDITLFHAMDTLQRNGYDLAKAMSTLVPQGGPVLCRDEMEEWSASEAMLFEEALEKYGKDFNDIRQDFLPWKSLASIVQFYYMWKTTDRYIQQKRLKAAEADSKLKQVYIPTYTKPNPNQIISVGSKPGMNGAGFQKGLTCESCHTTQSAQWYAWGPPNMQCRLCASCWIYWKKYGGLKTPTQLEGATRGTTEPHSRGHLSRPEAQSLSPYTTSANRAKLLAKNRQTFLLQTTKLTRLARRMCRDLLQPRRAARRPYAPINANAIKAECSIRLPKAAKTPLKIHPLVRLPLATIVKDLVAQAPLKPKTPRGTKTPINRNQLSQNRGLGGIMVKRAYETMAGAGVPFSANGRPLASGIRSSSQPAAKRQKLNPADAPNPVVFVATKDTRALRKALTHLEMRRAARRPNLPLKVKPTLIAVRPPVPLPAPSHPASTNEPIVLED | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MAANMYRVGDYVY --CCCCCEEECCEEE | 11.27 | 24043423 | |
11 | Phosphorylation | NMYRVGDYVYFENSS CCEEECCEEEEECCC | 7.36 | 22817900 | |
13 | Phosphorylation | YRVGDYVYFENSSSN EEECCEEEEECCCCC | 10.03 | 24719451 | |
17 | Phosphorylation | DYVYFENSSSNPYLV CEEEEECCCCCHHHH | 28.13 | 24043423 | |
18 | Phosphorylation | YVYFENSSSNPYLVR EEEEECCCCCHHHHH | 45.79 | 24043423 | |
19 | Phosphorylation | VYFENSSSNPYLVRR EEEECCCCCHHHHHH | 41.46 | 24719451 | |
22 | Phosphorylation | ENSSSNPYLVRRIEE ECCCCCHHHHHHHHH | 23.29 | 17360941 | |
32 | Acetylation | RRIEELNKTANGNVE HHHHHHHHHCCCCEE | 62.73 | 25953088 | |
32 | Ubiquitination | RRIEELNKTANGNVE HHHHHHHHHCCCCEE | 62.73 | 21890473 | |
41 | Acetylation | ANGNVEAKVVCLFRR CCCCEEEEEEEEEEC | 22.99 | 26051181 | |
41 | Ubiquitination | ANGNVEAKVVCLFRR CCCCEEEEEEEEEEC | 22.99 | - | |
52 | Phosphorylation | LFRRRDISSSLNSLA EEECCCCHHHHHHHH | 20.40 | 27794612 | |
53 | Phosphorylation | FRRRDISSSLNSLAD EECCCCHHHHHHHHH | 38.90 | 30266825 | |
54 | Phosphorylation | RRRDISSSLNSLADS ECCCCHHHHHHHHHH | 25.44 | 30266825 | |
57 | Phosphorylation | DISSSLNSLADSNAR CCHHHHHHHHHHCHH | 30.17 | 30266825 | |
61 | Phosphorylation | SLNSLADSNAREFEE HHHHHHHHCHHHHHH | 27.12 | 21406692 | |
70 | Phosphorylation | AREFEEESKQPGVSE HHHHHHHHCCCCCCH | 39.61 | 21815630 | |
71 | Acetylation | REFEEESKQPGVSEQ HHHHHHHCCCCCCHH | 64.89 | 26051181 | |
71 | Ubiquitination | REFEEESKQPGVSEQ HHHHHHHCCCCCCHH | 64.89 | 21890473 | |
105 | Acetylation | PATHIRGKCSVTLLN CCCEECCCCEEEEEC | 17.31 | 26051181 | |
152 | Acetylation | GEIRVGCKYQAEIPD CCEEECEEEEEECCC | 34.17 | 19608861 | |
152 | Malonylation | GEIRVGCKYQAEIPD CCEEECEEEEEECCC | 34.17 | 26320211 | |
152 | Ubiquitination | GEIRVGCKYQAEIPD CCEEECEEEEEECCC | 34.17 | 19608861 | |
160 | Methylation | YQAEIPDRLVEGESD EEEECCCCCCCCCCC | 34.97 | 115483943 | |
169 | Methylation | VEGESDNRNQQKMEM CCCCCCCHHHHCEEE | 47.53 | 115483951 | |
173 | Acetylation | SDNRNQQKMEMKVWD CCCHHHHCEEEEECC | 27.36 | 25953088 | |
173 | Methylation | SDNRNQQKMEMKVWD CCCHHHHCEEEEECC | 27.36 | 115483959 | |
173 | Ubiquitination | SDNRNQQKMEMKVWD CCCHHHHCEEEEECC | 27.36 | - | |
177 | Ubiquitination | NQQKMEMKVWDPDNP HHHCEEEEECCCCCC | 27.20 | - | |
188 | Methylation | PDNPLTDRQIDQFLV CCCCCCHHHHHHHHH | 30.07 | 115483935 | |
217 | Phosphorylation | SSSIRQPSLHMSAAA CCCCCCCCHHHHHHH | 23.67 | 21406692 | |
221 | Phosphorylation | RQPSLHMSAAAASRD CCCCHHHHHHHHHCC | 12.19 | 21406692 | |
226 | Phosphorylation | HMSAAAASRDITLFH HHHHHHHHCCHHHHH | 26.26 | 21406692 | |
237 | Phosphorylation | TLFHAMDTLQRNGYD HHHHHHHHHHHCCHH | 16.23 | 24945436 | |
282 | Ubiquitination | LFEEALEKYGKDFND HHHHHHHHHCCCHHH | 61.22 | - | |
285 | Ubiquitination | EALEKYGKDFNDIRQ HHHHHHCCCHHHHHH | 56.93 | - | |
320 | Ubiquitination | TDRYIQQKRLKAAEA HHHHHHHHHHHHHHH | 43.24 | - | |
332 | Acetylation | AEADSKLKQVYIPTY HHHCHHCCEEECCCC | 41.26 | 20167786 | |
335 | Phosphorylation | DSKLKQVYIPTYTKP CHHCCEEECCCCCCC | 9.93 | - | |
339 | Phosphorylation | KQVYIPTYTKPNPNQ CEEECCCCCCCCCCC | 13.86 | - | |
341 | Acetylation | VYIPTYTKPNPNQII EECCCCCCCCCCCEE | 32.17 | 20167786 | |
341 | Ubiquitination | VYIPTYTKPNPNQII EECCCCCCCCCCCEE | 32.17 | - | |
352 | Phosphorylation | NQIISVGSKPGMNGA CCEEEECCCCCCCCC | 33.26 | 25159151 | |
353 | Acetylation | QIISVGSKPGMNGAG CEEEECCCCCCCCCC | 39.39 | 25953088 | |
393 | Phosphorylation | MQCRLCASCWIYWKK HHCCHHHHHHHHHHH | 14.69 | 20860994 | |
397 | Phosphorylation | LCASCWIYWKKYGGL HHHHHHHHHHHCCCC | 6.15 | 20860994 | |
399 | Acetylation | ASCWIYWKKYGGLKT HHHHHHHHHCCCCCC | 21.10 | 26051181 | |
401 | Phosphorylation | CWIYWKKYGGLKTPT HHHHHHHCCCCCCCC | 16.82 | 23186163 | |
405 | Ubiquitination | WKKYGGLKTPTQLEG HHHCCCCCCCCCCCC | 56.59 | - | |
406 | Phosphorylation | KKYGGLKTPTQLEGA HHCCCCCCCCCCCCC | 36.29 | 25159151 | |
408 | Phosphorylation | YGGLKTPTQLEGATR CCCCCCCCCCCCCCC | 51.52 | 23186163 | |
414 | Phosphorylation | PTQLEGATRGTTEPH CCCCCCCCCCCCCCC | 40.25 | 23186163 | |
427 | Phosphorylation | PHSRGHLSRPEAQSL CCCCCCCCCHHHHCC | 39.86 | 25159151 | |
433 | Phosphorylation | LSRPEAQSLSPYTTS CCCHHHHCCCCCCCC | 37.55 | 25159151 | |
435 | Phosphorylation | RPEAQSLSPYTTSAN CHHHHCCCCCCCCHH | 22.55 | 20201521 | |
437 | Phosphorylation | EAQSLSPYTTSANRA HHHCCCCCCCCHHHH | 21.19 | 30266825 | |
438 | Phosphorylation | AQSLSPYTTSANRAK HHCCCCCCCCHHHHH | 20.05 | 30266825 | |
439 | Phosphorylation | QSLSPYTTSANRAKL HCCCCCCCCHHHHHH | 21.72 | 30266825 | |
440 | Phosphorylation | SLSPYTTSANRAKLL CCCCCCCCHHHHHHH | 18.75 | 30266825 | |
453 | Phosphorylation | LLAKNRQTFLLQTTK HHHHCCCHHHHHHHH | 17.02 | 28555341 | |
458 | Phosphorylation | RQTFLLQTTKLTRLA CCHHHHHHHHHHHHH | 26.35 | - | |
459 | Phosphorylation | QTFLLQTTKLTRLAR CHHHHHHHHHHHHHH | 15.87 | - | |
460 | Acetylation | TFLLQTTKLTRLARR HHHHHHHHHHHHHHH | 51.77 | - | |
460 | Ubiquitination | TFLLQTTKLTRLARR HHHHHHHHHHHHHHH | 51.77 | 21890473 | |
460 | Ubiquitination | TFLLQTTKLTRLARR HHHHHHHHHHHHHHH | 51.77 | 21890473 | |
483 | Phosphorylation | RRAARRPYAPINANA HHHHCCCCCCCCHHH | 24.17 | 28152594 | |
492 | Acetylation | PINANAIKAECSIRL CCCHHHEEEEEEEEC | 35.40 | 25953088 | |
496 | Phosphorylation | NAIKAECSIRLPKAA HHEEEEEEEECCCCC | 11.40 | 25159151 | |
504 | Ubiquitination | IRLPKAAKTPLKIHP EECCCCCCCCCCCCC | 56.38 | - | |
505 | Phosphorylation | RLPKAAKTPLKIHPL ECCCCCCCCCCCCCC | 29.18 | 23927012 | |
508 | Acetylation | KAAKTPLKIHPLVRL CCCCCCCCCCCCCCC | 39.92 | 26051181 | |
508 | Sumoylation | KAAKTPLKIHPLVRL CCCCCCCCCCCCCCC | 39.92 | 28112733 | |
508 | Ubiquitination | KAAKTPLKIHPLVRL CCCCCCCCCCCCCCC | 39.92 | 21890473 | |
508 | Ubiquitination | KAAKTPLKIHPLVRL CCCCCCCCCCCCCCC | 39.92 | 21890473 | |
519 | Phosphorylation | LVRLPLATIVKDLVA CCCCCHHHHHHHHHH | 33.70 | 20068231 | |
522 | Acetylation | LPLATIVKDLVAQAP CCHHHHHHHHHHCCC | 41.30 | - | |
522 | Ubiquitination | LPLATIVKDLVAQAP CCHHHHHHHHHHCCC | 41.30 | 21890473 | |
522 | Ubiquitination | LPLATIVKDLVAQAP CCHHHHHHHHHHCCC | 41.30 | 21890473 | |
531 | Acetylation | LVAQAPLKPKTPRGT HHHCCCCCCCCCCCC | 43.33 | 23954790 | |
531 | Ubiquitination | LVAQAPLKPKTPRGT HHHCCCCCCCCCCCC | 43.33 | - | |
534 | Phosphorylation | QAPLKPKTPRGTKTP CCCCCCCCCCCCCCC | 27.09 | 25159151 | |
538 | Phosphorylation | KPKTPRGTKTPINRN CCCCCCCCCCCCCHH | 32.78 | 30576142 | |
539 | Ubiquitination | PKTPRGTKTPINRNQ CCCCCCCCCCCCHHH | 55.94 | - | |
540 | Phosphorylation | KTPRGTKTPINRNQL CCCCCCCCCCCHHHH | 29.28 | 20068231 | |
548 | Phosphorylation | PINRNQLSQNRGLGG CCCHHHHHCCCCCCH | 18.69 | 25159151 | |
551 | Methylation | RNQLSQNRGLGGIMV HHHHHCCCCCCHHHH | 33.79 | 115483927 | |
559 | Acetylation | GLGGIMVKRAYETMA CCCHHHHHHHHHHHC | 17.58 | 25953088 | |
559 | Methylation | GLGGIMVKRAYETMA CCCHHHHHHHHHHHC | 17.58 | 7614655 | |
559 | Sumoylation | GLGGIMVKRAYETMA CCCHHHHHHHHHHHC | 17.58 | 28112733 | |
559 | Ubiquitination | GLGGIMVKRAYETMA CCCHHHHHHHHHHHC | 17.58 | - | |
562 | Phosphorylation | GIMVKRAYETMAGAG HHHHHHHHHHHCCCC | 18.90 | - | |
564 | Phosphorylation | MVKRAYETMAGAGVP HHHHHHHHHCCCCCC | 10.31 | 20068231 | |
573 | Phosphorylation | AGAGVPFSANGRPLA CCCCCCCCCCCCCCC | 18.11 | 29978859 | |
581 | Phosphorylation | ANGRPLASGIRSSSQ CCCCCCCCCCCCCCC | 42.30 | 20068231 | |
586 | Phosphorylation | LASGIRSSSQPAAKR CCCCCCCCCCHHHHH | 24.12 | 28555341 | |
587 | Phosphorylation | ASGIRSSSQPAAKRQ CCCCCCCCCHHHHHH | 41.24 | 26853621 | |
592 | Acetylation | SSSQPAAKRQKLNPA CCCCHHHHHHCCCCC | 58.42 | 30585581 | |
595 | Acetylation | QPAAKRQKLNPADAP CHHHHHHCCCCCCCC | 55.02 | 25953088 | |
595 | Sumoylation | QPAAKRQKLNPADAP CHHHHHHCCCCCCCC | 55.02 | 28112733 | |
610 | Phosphorylation | NPVVFVATKDTRALR CCEEEEEECCHHHHH | 24.93 | 22210691 | |
611 | Acetylation | PVVFVATKDTRALRK CEEEEEECCHHHHHH | 47.57 | 25953088 | |
611 | Ubiquitination | PVVFVATKDTRALRK CEEEEEECCHHHHHH | 47.57 | 21890473 | |
611 | Ubiquitination | PVVFVATKDTRALRK CEEEEEECCHHHHHH | 47.57 | 21890473 | |
621 | Phosphorylation | RALRKALTHLEMRRA HHHHHHHHHHHHHHH | 29.31 | - | |
655 | Phosphorylation | PVPLPAPSHPASTNE CCCCCCCCCCCCCCC | 44.18 | 28555341 | |
659 | Phosphorylation | PAPSHPASTNEPIVL CCCCCCCCCCCCCCC | 35.90 | 27251275 | |
660 | Phosphorylation | APSHPASTNEPIVLE CCCCCCCCCCCCCCC | 45.79 | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of MTA2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MTA2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MTA2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-152, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433; SER-435; THR-505AND THR-534, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435, AND MASSSPECTROMETRY. | |
"Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-435, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-57, AND MASSSPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-540, AND MASSSPECTROMETRY. |